Last reviewed: June 11, 2026
Last updated: June 11, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide, a dual GLP-1 and GIP receptor agonist, reduces hunger while improving insulin sensitivity—mechanisms that have produced average weight losses of 20% in clinical trials. Many patients wonder whether adding NAD+ boosters, which support cellular energy and metabolism, could amplify results or create unwanted interactions. This guide breaks down the evidence and explains how PlexusDx personalizes your therapy to prevent conflicts between compounds.
How Tirzepatide and NAD+ Work Differently in Your Body
Tirzepatide activates two hormone pathways—GLP-1 and GIP—that signal fullness to your brain, slow stomach emptying, and improve how your pancreas releases insulin. NAD+, or nicotinamide adenine dinucleotide, is a coenzyme involved in mitochondrial function, DNA repair, and energy metabolism at the cellular level. While tirzepatide is a prescription injectable that reshapes appetite and glucose control, NAD+ boosters (like NMN or nicotinamide riboside) work through a different biochemical system entirely.
The two compounds operate on separate biological pathways. Tirzepatide's effects on your GLP-1 and GIP receptors do not directly interfere with NAD+ synthesis or metabolism. However, both can influence energy expenditure, insulin sensitivity, and mitochondrial health—which means their effects on weight loss occur through partly overlapping systems, even if the mechanisms are distinct.
Potential Interactions Between NAD+ and Tirzepatide
No major drug interactions have been documented between tirzepatide and NAD+ boosters in clinical literature or pharmacovigilance databases. NAD+ is a natural coenzyme, not a drug that binds to the same receptors or enzymes as tirzepatide, making serious interactions unlikely. However, both compounds can lower blood pressure and improve insulin sensitivity—effects that are generally beneficial but require monitoring if you are already on blood pressure or diabetes medications.
The more relevant concern is metabolic redundancy: if you are taking tirzepatide for appetite suppression and weight loss, adding NAD+ boosters that also increase cellular energy expenditure might produce unexpectedly rapid metabolic changes. Some patients report increased energy, improved sleep, or enhanced workout recovery on NAD+ protocols, which could alter how you experience tirzepatide's side effects. This is why PlexusDx recommends discussing supplement stacking with your clinician before starting both simultaneously.
Why Genetic Testing Matters When Combining Metabolic Therapies
Not all patients respond equally to tirzepatide or benefit equally from NAD+ support. PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptide-related genes to identify how your body processes GLP-1, GIP, and other appetite and energy hormones. Key variants in GLP1R (rs6923761), GIPR (rs1800437), and MC4R (rs17782313) determine whether you are a fast, average, or slow responder to tirzepatide's signaling.
If your genetic profile shows you have lower baseline GLP-1 receptor sensitivity, you may benefit from maximizing every lever of metabolic support, including NAD+ restoration. Conversely, if you carry variants that amplify GLP-1 signaling, adding NAD+ might create overly aggressive appetite suppression or energy shifts. PlexusDx uses your genetic data to map safe, effective combinations tailored to your peptide pathways—not generic supplement stacks.
Safe Timing and Practical Steps for NAD+ + Tirzepatide
If you and your PlexusDx clinician decide NAD+ supplementation is right for you, separate timing can minimize any overlap in absorption and effects. Most NAD+ boosters are taken orally in the morning or evening with food; tirzepatide injections are administered once weekly on a set day. Spacing them by several hours and monitoring your energy, appetite, and blood sugar for the first 2–4 weeks will reveal whether the combination is tolerable and effective for you.
Start NAD+ at the lowest recommended dose (typically 250–500 mg daily) and observe changes in sleep quality, exercise performance, and hunger cues. PlexusDx recommends keeping a log of your weight, energy levels, and any gastrointestinal symptoms when you introduce a new supplement on top of tirzepatide. If you experience dizziness, severe nausea, or unusual blood sugar swings, pause the NAD+ and contact your PlexusDx clinician to rule out unexpected interactions or dosing conflicts.
The Role of Personalized Precision in Metabolic Stacking
Generic advice to 'stack NAD+ with GLP-1' ignores the fact that your genetic makeup, current medications, and metabolic state are unique. PlexusDx goes beyond standard tirzepatide dosing by offering the Precision Peptide Genetic Test ($99 add-on after your first month of treatment), which decodes how your body responds to peptide-pathway activation. Armed with this insight, your clinician can endorse, adjust, or advise against NAD+ use with confidence.
PlexusDx Tirzepatide Injection starts at $249/month with no flat per-compound pricing—your dose may need to go up, but your price won't. Combining that affordability with genetic personalization ensures you are not paying extra for generic recommendations or trial-and-error supplementation. Instead, every addition to your weight loss plan is grounded in your biology and monitored by a clinician who understands both tirzepatide and your peptide genetics.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is it safe to take NAD+ boosters while on tirzepatide injections?
No direct drug interactions have been reported between NAD+ supplements and tirzepatide. However, both can influence insulin sensitivity and energy metabolism, so it is important to start NAD+ at a low dose, monitor your response, and discuss the combination with your PlexusDx clinician before proceeding. They can review your medications and genetic profile to ensure safety.
Can NAD+ enhance tirzepatide's weight loss effects?
NAD+ supports mitochondrial energy and may improve cellular metabolism, which could theoretically complement tirzepatide's appetite-suppressing and insulin-sensitizing effects. However, clinical evidence specifically testing NAD+ plus GLP-1 agonists is limited. Personalized genetic testing through PlexusDx can help identify whether your metabolic pathways would benefit from NAD+ support alongside tirzepatide.
How much does PlexusDx Tirzepatide Injection cost, and can I add supplements like NAD+ without extra fees?
PlexusDx Tirzepatide Injection starts at $249/month, with pricing that stays flat regardless of your dose—your dose may need to go up, but your price won't. You can add NAD+ or other supplements independently; PlexusDx does not charge extra for supplement counseling or monitoring. The optional Precision Peptide Genetic Test ($99 add-on) helps personalize your entire protocol, including whether supplement stacking is right for you.
Should I be concerned about low blood pressure or blood sugar if I combine NAD+ with tirzepatide?
Both tirzepatide and NAD+ can lower blood pressure and improve insulin sensitivity, which is usually beneficial. However, if you already take blood pressure or diabetes medications, the combination could theoretically increase the risk of hypotension or hypoglycemia. Your PlexusDx clinician will review your complete medication list and adjust tirzepatide dosing or NAD+ use to keep you safe.
How does PlexusDx Precision Peptide Genetic Testing help me decide about NAD+ supplementation?
PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, MC4R, and 11 other pathways to reveal how efficiently your body responds to tirzepatide and other metabolic signals. If your genetics show lower GLP-1 receptor sensitivity, you may benefit from NAD+ to boost mitochondrial energy. If your variants show strong GLP-1 signaling, adding NAD+ might be unnecessary. This personalization prevents wasted money on supplements that don't match your biology.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Is a GLP-1 Probiotic and How Can It Enhance Your Metabolic Health?
Has the FDA Approved Ozempic for Weight Loss? Exploring the Facts